11 results
6-K
LEGN
Legend Biotech Corp
13 May 24
Legend Biotech Reports First Quarter 2024 Results and Recent Highlights
7:01am
, the collaborator may recoup the aggregate amount of Funding Advances, together with interest thereon, from Company’s share of pre-tax profits from the first … CME term Secured Overnight Financing Rate (“SOFR”) plus LIBOR/SOFR adjustment (12 month) plus a margin of 2.5%. Janssen has the right to recoup
6-K
LEGN
Legend Biotech Corp
20 Nov 23
Legend Biotech Reports Third Quarter 2023 Results and Recent Highlights
6:02am
, 2022, respectively
Pursuant to the terms of the Janssen Agreement, Janssen may recoup the aggregate amount of Funding Advances, together with interest … accrue interest at 12-month CME Term SOFR plus LIBOR/SOFR adjustment (12 month) plus a margin of 2.5%. Janssen has the right to recoup such advances
6-K
LEGN
Legend Biotech Corp
15 Aug 23
Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
6:10am
, September 16, 2022, and December 16, 2022, respectively
Pursuant to the terms of the Janssen Agreement, Janssen may recoup the aggregate amount … advances accrue interest at the London Interbank Offered Rate (LIBOR) published by the Wall Street Journal plus 2.5%. Janssen has the right to recoup
6-K
EX-99.2
uujdnme67 w5twm
25 Jul 22
Legend Biotech Corporation Announces Proposed Public Offering
4:07pm
6-K
EX-99.3
j60zdb4ocmz19tpsogl9
25 Jul 22
Legend Biotech Corporation Announces Proposed Public Offering
4:07pm
6-K
EX-99.2
sesgjkcz
14 Dec 21
Legend Biotech Corporation Announces Proposed Public Offering
4:27pm
6-K
sokqv
23 Aug 21
Current report (foreign)
8:16am
- Prev
- 1
- Next